Clinical Trial Update: Next Generation Rocklatan [Phase 2]

View source ↗

Summary

A Phase 2 study of the next generation Rocklatan for open angle glaucoma and ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• ROCKLATAN (Netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%)

Snippet

Sponsor: Alcon Research | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED